| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
3 companies
Springer Timothy A is a Director, 10% Owner at Cartesian Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 27 buys and 0 sells.
Estimated insider holdings value: $240.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2024 | TECX Tectonic Therapeutic, Inc. | Director, 10% Owner | Buy | 50,000 | $28.82 | $1,440,828.83 | +0.3% | +79.1% | -46.8% | |
| Aug 12, 2024 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 8,016 | $12.72 | $101,967.53 | +229.5% | +55.7% | -10.8% | |
| Mar 18, 2024 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 19,044 | $0.60 | $11,397.83 | - | +23.0% | -23.0% | |
| Mar 18, 2024 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 18,400 | $0.62 | $11,442.24 | +1.9% | +23.0% | -23.0% | |
| Mar 15, 2024 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 1,185,872 | $0.56 | $666,221.97 | +2.0% | +68.2% | -9.2% | |
| Apr 11, 2022 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 6,681,600 | $0.00 | - | +28.8% | +47.7% | +20.2% | |
| Dec 15, 2021 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 211,190 | $2.99 | $631,099.08 | +0.9% | -54.1% | -60.7% | |
| Dec 13, 2021 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 3,821,273 | $3.06 | $11,687,810.04 | +5.9% | -52.4% | -56.3% | |
| May 26, 2021 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 1,900,000 | $3.72 | $7,059,872.31 | +3.6% | -1.5% | -82.9% | |
| May 21, 2021 | RNAC Cartesian Therapeutics, Inc. | Director, 10% Owner | Buy | 2,773,479 | $3.19 | $8,847,398.01 | +19.2% | +19.7% | -75.1% |